Posted in | News | Nanomaterials | Nanobusiness

NaturalNano and NRL Extend Licensing Agreement

NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N), a provider of advanced nanomaterial and additive technology, announced it has signed an extension to its patent licensing agreement with the U.S. Naval Research Laboratory (NRL) covering the commercialization of products based on five (5) patents for extended release technologies.

NaturalNano's Acting CEO & President, James Wemett said, "The extension of this license agreement continues our relationship with the NRL. This relationship advances our strategic plan to commercialize products for a diverse range of markets and solidify our position as a leader in advanced nanomaterials." Wemett continued, "The continued opportunity to utilize and bring NRL's research technology to market and capitalize on the potential inherent in extended release applications is very important to NaturalNano."

Under the license agreement with NRL, NaturalNano has been granted rights to develop and commercialize five very important patents which will be utilized in the NNAN work in the cosmetics and fragrances fields. The continuation of the agreement bolsters NaturalNano's industry-leading intellectual property portfolio in nanomaterials, bringing the Company's total number of patents or pending applications, exclusively owned or licensed, to more than 20.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NaturalNano, Inc.. (2019, February 12). NaturalNano and NRL Extend Licensing Agreement. AZoNano. Retrieved on February 22, 2024 from

  • MLA

    NaturalNano, Inc.. "NaturalNano and NRL Extend Licensing Agreement". AZoNano. 22 February 2024. <>.

  • Chicago

    NaturalNano, Inc.. "NaturalNano and NRL Extend Licensing Agreement". AZoNano. (accessed February 22, 2024).

  • Harvard

    NaturalNano, Inc.. 2019. NaturalNano and NRL Extend Licensing Agreement. AZoNano, viewed 22 February 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type